Literature DB >> 16321660

Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.

Giuseppe Coppola1, Egle Corrado, Ida Muratori, Rosalba Tantillo, Giustina Vitale, L Lo Coco, Salvatore Novo.   

Abstract

AIM: To evaluate the predictive role of hs-CRP and fibrinogen for cardio- and cerebrovascular events in a population of patients with type 2 diabetes.
METHODS: We studied 156 patients with type 2 diabetes, mean age 66+10 years, and 156 sex and age matched control subjects. Patients underwent physical examination, EKG, measurement of body mass index and blood pressure. A blood sample was drawn to evaluate glycaemia, total and HDL/LDL cholesterol, triglycerides, high sensitive C-reactive protein (hs-CRP), fibrinogen. Finally, patients underwent an ecocolordoppler examination of the common carotid arteries until the bifurcation. In a follow-up of 5+/-1.2 years we evaluated the following events: transient ischemic attack, ischemic stroke, stable or unstable angina, acute myocardial infarction, critical limb ischemia and cardiovascular death.
RESULTS: During the follow-up the prevalence of fatal (p<0.05) and non fatal events (p<0.0001) was higher in patients with diabetes in comparison with controls. The variables independently associated with non fatal events were: fibrinogen (p<0.0001), presence of asymptomatic carotid lesion (p<0.005), obesity (p<0.05) and plasma levels of hs-CRP (p<0.05), while fibrinogen (p<0.001) and age were (p<0.05) independently associated with fatal events.
CONCLUSION: Our data show that in patients with diabetes mellitus, that in the follow-up the presence of high plasma levels of hs-CRP and fibrinogen are predictive for fatal or non fatal events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16321660     DOI: 10.1016/j.ijcard.2004.12.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

Review 1.  Cardiovascular risk assessment in type 2 diabetes mellitus.

Authors:  Ebaa Al-Ozairi; R Jan-Willem Middelbeek; Edward S Horton
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 2.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

3.  High levels of hsCRP are associated with carbohydrate metabolism disorder.

Authors:  Elba Leiva; Verónica Mujica; Katherine Brito; Ivan Palomo; Roxana Orrego; Rodrigo Moore-Carrasco; Marcela Vásquez; Luis Guzmán; Sergio Nuñez; Nora Díaz; Gloria Icaza; Miguel Arredondo
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

4.  The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.

Authors:  Milan Gupta; Hwee Teoh; Mahesh Kajil; Michelle Tsigoulis; Adrian Quan; Manoela Fb Braga; Subodh Verma
Journal:  Exp Clin Cardiol       Date:  2012

5.  Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.

Authors:  Yiliang Bi; Min Min; Wei Shen; Pei Deng; Qiupeng Du; Mingjie Dong; Yan Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  Diabetes, depressive symptoms, and inflammation in older adults: results from the Health, Aging, and Body Composition Study.

Authors:  Todd A Doyle; Mary de Groot; Tamara Harris; Frank Schwartz; Elsa S Strotmeyer; Karen C Johnson; Alka Kanaya
Journal:  J Psychosom Res       Date:  2013-08-16       Impact factor: 3.006

7.  Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects.

Authors:  Aneta Mankowska; Joanna Pollak; Grazyna Sypniewska
Journal:  EJIFCC       Date:  2006-03-20

8.  Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.

Authors:  Shahnam Sharif; Y Van der Graaf; M J Cramer; L J Kapelle; G J de Borst; Frank L J Visseren; Jan Westerink
Journal:  Cardiovasc Diabetol       Date:  2021-11-09       Impact factor: 9.951

9.  Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes.

Authors:  Majid Mohamadshahi; Masoud Veissi; Fatemeh Haidari; Hajieh Shahbazian; Gholam-Abas Kaydani; Fatemeh Mohammadi
Journal:  Bioimpacts       Date:  2014-06-11

10.  Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty.

Authors:  Eluisa La Franca; Marco Caruso; Angela Sansone; Rosanna Iacona; Laura Ajello; Dario Mancuso; Fabiana Castellano; Salvatore Novo; Pasquale Assennato
Journal:  Glob J Health Sci       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.